These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 35043090)
21. Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality. He Q; Zhao MM; Li MJ; Li XY; Jin JM; Feng YM; Zhang L; Huang WJ; Yang F; Yang JK Elife; 2024 Aug; 13():. PubMed ID: 39150053 [TBL] [Abstract][Full Text] [Related]
22. Impact of Diabetes in Patients Diagnosed With COVID-19. Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J Front Immunol; 2020; 11():576818. PubMed ID: 33335527 [TBL] [Abstract][Full Text] [Related]
23. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
24. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner. Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768 [TBL] [Abstract][Full Text] [Related]
25. Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19. Chen CF; Chien CH; Yang YP; Chou SJ; Wang ML; Huo TI; Lin CC J Chin Med Assoc; 2020 Aug; 83(8):710-711. PubMed ID: 32349031 [TBL] [Abstract][Full Text] [Related]
26. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella. Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A Front Immunol; 2020; 11():1714. PubMed ID: 32793244 [TBL] [Abstract][Full Text] [Related]
27. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane? Jagat J M; Kalyan K G; Subir R Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737 [TBL] [Abstract][Full Text] [Related]
28. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. Rajpal A; Rahimi L; Ismail-Beigi F J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936 [TBL] [Abstract][Full Text] [Related]
29. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. Viurcos-Sanabria R; Escobedo G World J Diabetes; 2021 Jul; 12(7):1026-1041. PubMed ID: 34326952 [TBL] [Abstract][Full Text] [Related]
30. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study. Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952 [TBL] [Abstract][Full Text] [Related]
31. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? Filardi T; Morano S J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299 [TBL] [Abstract][Full Text] [Related]
32. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report. Jornayvaz FR; Assouline B; Pugin J; Gariani K BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762 [TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection? Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379 [TBL] [Abstract][Full Text] [Related]
34. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review. Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187 [TBL] [Abstract][Full Text] [Related]
35. Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers. Geetha HS; Singh G; Sekar A; Gogtay M; Singh Y; Abraham GM; Trivedi N World J Clin Cases; 2023 Feb; 11(6):1287-1298. PubMed ID: 36926123 [TBL] [Abstract][Full Text] [Related]
36. How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection? Lugito NPH; Cucunawangsih C Mycopathologia; 2021 Dec; 186(6):877-882. PubMed ID: 34623597 [TBL] [Abstract][Full Text] [Related]
37. Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality. Mir MM; Mir R; Alghamdi MAA; Alsayed BA; Wani JI; Alharthi MH; Al-Shahrani AM J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834450 [TBL] [Abstract][Full Text] [Related]
38. COVID-19 and Diabetes. Singh AK; Khunti K Annu Rev Med; 2022 Jan; 73():129-147. PubMed ID: 34379444 [TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area. Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712 [TBL] [Abstract][Full Text] [Related]